NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), announced today that its current joint venture target, Amarantus BioSciences, Inc. (OTCBB: AMBS), has cited several new peer-reviewed articles detailing its new protein therapy MANF to its website, bringing the total to 20.
